Literature DB >> 7724700

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

H E Molewijk1, A M van der Poel, J Mos, J A van der Heyden, B Olivier.   

Abstract

Rats may produce ultrasonic vocalizations (USV) in threatening situations. USV of adult male rats in association with aversive stimulation was evaluated as a screening method for anxiolytic drugs. The triazolobenzodiazepine alprazolam, the 5-HT uptake inhibitors fluvoxamine and clomipramine, the mixed 5-HT/NA uptake inhibitor imipramine, the full 5-HT1A receptor agonists 8-OH-DPAT and flesinoxan, the partial 5-HT1A receptor agonists buspirone, ipsapirone and BMY 7378, the alpha 2-adrenoceptor agonist clonidine and the alpha 2-adrenoceptor antagonist yohimbine reduced conditioned USV. The classical benzodiazepines (BZD) diazepam and chlordiazepoxide were ineffective or had a very low potency to decrease USV. The partial BZD receptor agonists bretazenil, alpidem and zolpidem, the BZD receptor antagonist flumazenil, the NA uptake inhibitors desipramine and maprotiline, and the 5-HT3 receptor antagonist ondansetron had no effect on conditioned USV. The dopamine-D2 receptor antagonist haloperidol reduced USV at a very high dose. In separate experiments the effects of these drugs on locomotor activity were assessed. There was, however, no direct relationship between effects on motor behaviour and USV. In conclusion, the sensitivity of conditioned USV to 5-HT uptake inhibitors and alprazolam versus the insensitivity to classical benzodiazepines and NA uptake inhibitors provides a very interesting profile, which closely resembles the psychopharmacology of panic disorder. Also the face validity of conditioned USV towards situational panic attacks is high. We therefore propose conditioned USV in adult male rats as a novel behavioural paradigm to screen for anti-panic drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724700     DOI: 10.1007/bf02245095

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

1.  Isolation distress in two-week-old rats: influence of home cage, social companions, and prior experience with littermates.

Authors:  M A Hofer; H N Shair
Journal:  Dev Psychobiol       Date:  1987-07       Impact factor: 3.038

2.  Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.

Authors:  J A den Boer; H G Westenberg; W D Kamerbeek; W M Verhoeven; R S Kahn
Journal:  Int Clin Psychopharmacol       Date:  1987-01       Impact factor: 1.659

3.  Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats.

Authors:  C. Sánchez
Journal:  Behav Pharmacol       Date:  1993-06       Impact factor: 2.293

Review 4.  The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.

Authors:  D J Sanger; G Perrault; E Morel; D Joly; B Zivkovic
Journal:  Physiol Behav       Date:  1987

5.  Acoustic startle induced ultrasonic vocalization in the rat: a novel animal model of anxiety?

Authors:  M T Kaltwasser
Journal:  Behav Brain Res       Date:  1991-05-15       Impact factor: 3.332

6.  The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.

Authors:  S E File; S Pellow
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

7.  Alpidem in the treatment of panic disorder.

Authors:  F R Schneier; J L Carrasco; E Hollander; R Campeas; B Fallon; J B Saoud; J Feerick; M R Liebowitz
Journal:  J Clin Psychopharmacol       Date:  1993-04       Impact factor: 3.153

8.  Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

Authors:  D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Authors:  J C Ballenger; G D Burrows; R L DuPont; I M Lesser; R Noyes; J C Pecknold; A Rifkin; R P Swinson
Journal:  Arch Gen Psychiatry       Date:  1988-05

10.  Treatment of agoraphobia with group exposure in vivo and imipramine.

Authors:  C M Zitrin; D F Klein; M G Woerner
Journal:  Arch Gen Psychiatry       Date:  1980-01
View more
  10 in total

1.  Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT.

Authors:  S M Remy; R Schreiber; M Dalmus; J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 2.  Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

Authors:  K A Miczek; E M Weerts; J A Vivian; H M Barros
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

3.  Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

Authors:  C Sánchez; E Meier
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

4.  Fear-potentiated startle response is remarkably similar in two laboratories.

Authors:  R J Joordens; T H Hijzen; B W Peeters; B Olivier
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

5.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

6.  Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide.

Authors:  Alexa Mead; Ming Li; Shitij Kapur
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

7.  A rodent "self-report" measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement.

Authors:  Stephen V Mahler; David E Moorman; Matthew W Feltenstein; Brittney M Cox; Katelyn B Ogburn; Michal Bachar; Justin T McGonigal; Shannon M Ghee; Ronald E See
Journal:  Behav Brain Res       Date:  2012-08-24       Impact factor: 3.332

8.  Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.

Authors:  Adam J Prus; Todd M Hillhouse; Amber L LaCrosse
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-11-23       Impact factor: 5.067

Review 9.  Rat Ultrasonic Vocalizations and Behavioral Neuropharmacology: From the Screening of Drugs to the Study of Disease.

Authors:  Nicola Simola
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.

Authors:  Mark J Millan; Mauricette Brocco; Alain Gobert; Anne Dekeyne
Journal:  Psychopharmacology (Berl)       Date:  2004-07-31       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.